date:Aug 10, 2012
, said Watkins. There is also intense debate about whether the use of probiotic bacterial strain names will be allowed either, he added, since these could be argued to constitute an implied claim.
One of the biggest challenges about the regulation is understanding the breadth of what is and is not a health claim,said Watkins.In those scenarios one could see Trading Standards thinking, well maybe that is an implied claim. But there is a requirement [on labelling] to be specific about what the in